Pintera J, Vacl J, Valnícek S, Hill Z
Folia Haematol Int Mag Klin Morphol Blutforsch. 1978;105(4):544-51.
The examination by means of counterimmunoelectrophoresis for protein incompatibility of the serum of 62 patients who developed an allergic or pyretic post-transfusion reaction revealed incompatibility in 23 cases (37.2%). It was due to the presence of antibodies in 8 recipients (34.8%) and in 15 blood donors (65.2%). The incidence was significantly higher than in a control group of transfused patients who did not develop a reaction. In this group protein incompatibility was found in only 14.7%, 80% of which was due to antibodies in the recipient. In 13 (56.5%) of the patients with reactions agglutinating, cytotoxic or complement fixing antibodies against cellular antigens or IgG were found in addition to protein incompatibility. In 10 cases (43.5%) protein incompatibility was the only explanation for the clinical symptoms. When, in the treatment of multiply transfused haemophiliacs who regularly developed adverse reactions, donors for the preparation of cryoprecipitate were selected by means of the described technique, the almost obligatory reactions were prevented.
对62例发生过敏或发热性输血后反应患者的血清进行蛋白不相容性的对流免疫电泳检查发现,23例(37.2%)存在不相容性。这是由于8名受血者(34.8%)和15名献血者(65.2%)体内存在抗体。该发生率显著高于未发生反应的输血患者对照组。在该对照组中,仅14.7%发现蛋白不相容性,其中80%是由于受血者体内的抗体。在13例(56.5%)发生反应的患者中,除蛋白不相容性外,还发现了针对细胞抗原的凝集、细胞毒性或补体结合抗体或IgG。在10例(43.5%)患者中,蛋白不相容性是临床症状的唯一解释。当采用所述技术为经常发生不良反应的多次输血血友病患者选择制备冷沉淀的献血者时,几乎必然发生的反应得到了预防。